These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 16520989
1. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells. Yang B, Fan L, Fang L, He Q. Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989 [Abstract] [Full Text] [Related]
2. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation. Kang MH, Wan Z, Kang YH, Sposto R, Reynolds CP. J Natl Cancer Inst; 2008 Apr 16; 100(8):580-95. PubMed ID: 18398104 [Abstract] [Full Text] [Related]
3. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Batra S, Reynolds CP, Maurer BJ. Cancer Res; 2004 Aug 01; 64(15):5415-24. PubMed ID: 15289350 [Abstract] [Full Text] [Related]
4. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide. Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A. Anticancer Res; 2005 Aug 01; 25(3B):1945-51. PubMed ID: 16158929 [Abstract] [Full Text] [Related]
5. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F. Cancer Res; 2006 Mar 15; 66(6):3238-47. PubMed ID: 16540676 [Abstract] [Full Text] [Related]
6. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer. Brewer M, Wharton JT, Wang J, McWatters A, Auersperg N, Gershenson D, Bast R, Zou C. Gynecol Oncol; 2005 Aug 15; 98(2):182-92. PubMed ID: 15907982 [Abstract] [Full Text] [Related]
7. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids. Cuperus R, Tytgat GA, Leen R, Brites P, Bras J, Caron HN, Van Kuilenburg AB. Int J Oncol; 2008 May 15; 32(5):1011-9. PubMed ID: 18425327 [Abstract] [Full Text] [Related]
8. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells. Roberson KM, Penland SN, Padilla GM, Selvan RS, Kim CS, Fine RL, Robertson CN. Cell Growth Differ; 1997 Jan 15; 8(1):101-11. PubMed ID: 8993839 [Abstract] [Full Text] [Related]
9. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells. Yang X, Hao Y, Ding Z, Pater A. Exp Cell Res; 2000 May 01; 256(2):491-9. PubMed ID: 10772821 [Abstract] [Full Text] [Related]
10. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2. Morales MC, Pérez-Yarza G, Rementería NN, Boyano MD, Apraiz A, Gómez-Muñoz A, Pérez-Andrés E, Asumendi A. Free Radic Res; 2007 May 01; 41(5):591-601. PubMed ID: 17454142 [Abstract] [Full Text] [Related]
11. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Faderl S, Lotan R, Kantarjian HM, Harris D, Van Q, Estrov Z. Leuk Res; 2003 Mar 01; 27(3):259-66. PubMed ID: 12537979 [Abstract] [Full Text] [Related]
12. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells. Shan D, Gopal AK, Press OW. Clin Cancer Res; 2001 Aug 01; 7(8):2490-5. PubMed ID: 11489831 [Abstract] [Full Text] [Related]
13. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells. Appierto V, Villani MG, Cavadini E, Gariboldi M, De Cecco L, Pierotti MA, Lambert JR, Reid J, Tiberio P, Colombo N, Formelli F. Oncogene; 2007 Jun 07; 26(27):3952-62. PubMed ID: 17213814 [Abstract] [Full Text] [Related]
15. N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells. Darwiche N, Hatoum A, Dbaibo G, Kadara H, Nasr R, Abou-Lteif G, Bazzi R, Hermine O, de Thé H, Bazarbachi A. Leukemia; 2004 Mar 07; 18(3):607-15. PubMed ID: 14712289 [Abstract] [Full Text] [Related]
16. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. O'Donnell PH, Guo WX, Reynolds CP, Maurer BJ. Leukemia; 2002 May 07; 16(5):902-10. PubMed ID: 11986953 [Abstract] [Full Text] [Related]
17. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR. Holmes WF, Soprano DR, Soprano KJ. J Cell Biochem; 2003 May 15; 89(2):262-78. PubMed ID: 12704790 [Abstract] [Full Text] [Related]
18. [Mechanisms of fenretinide-triggered apoptosis in leukemic cells]. Xiao DK, Du YZ, Fan HY, Chen YL, Chen Z, Zhang J, Wang KK. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec 15; 13(6):975-8. PubMed ID: 16403262 [Abstract] [Full Text] [Related]
19. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Kouhara J, Yoshida T, Nakata S, Horinaka M, Wakada M, Ueda Y, Yamagishi H, Sakai T. Int J Oncol; 2007 Mar 15; 30(3):679-87. PubMed ID: 17273769 [Abstract] [Full Text] [Related]
20. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor. Anding AL, Chapman JS, Barnett DW, Curley RW, Clagett-Dame M. Cancer Res; 2007 Jul 01; 67(13):6270-7. PubMed ID: 17616685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]